• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

MINAGAWA HIKARU  皆川 光

ORCIDConnect your ORCID iD *help
… Alternative Names

Minagawa Hikaru  皆川 光

Less
Researcher Number 60792132
Other IDs
Affiliation (Current) 2025: 大阪大学, 大学院医学系研究科, 特任助教(常勤)
Affiliation (based on the past Project Information) *help 2023: 大阪大学, 大学院医学系研究科, 特任助教(常勤)
2020 – 2023: 大阪大学, 医学部附属病院, 医員
2017 – 2018: 大阪大学, 医学部附属病院, 医員
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / Pediatrics
Except Principal Investigator
Basic Section 52050:Embryonic medicine and pediatrics-related
Keywords
Principal Investigator
がん免疫 / WT1 / 経口ワクチン / 腸管免疫 / 癌ワクチン / ビフィズス菌 / 腸内細菌 / 腫瘍免疫 / がんワクチン / 抗腫瘍効果 … More / 拒絶実験 / ヘルパー機能 / WT1特異的CTL / 白血病 / 腫瘍浸潤リンパ球 / 放射線治療 / 頭蓋内接種 / 腫瘍内浸潤リンパ球 / 血液脳関門 / 脳腫瘍 / 小児がん / 経口がんワクチン / 免疫療法 / がん / エピトープ / 経口 … More
Except Principal Investigator
免疫細胞の動態 / WT1 / 樹状細胞 / パイエル板 / 腸管免疫 / がんワクチン / KikGRマウス / ビフィズス菌 Less
  • Research Projects

    (4 results)
  • Research Products

    (4 results)
  • Co-Researchers

    (5 People)
  •  ヘルパーエピトープを含む新規WT1経口がんワクチンの効果Principal Investigator

    • Principal Investigator
      皆川 光
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Osaka University
  •  腸管細胞の獲得免疫における動態評価

    • Principal Investigator
      橋井 佳子
    • Project Period (FY)
      2021 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52050:Embryonic medicine and pediatrics-related
    • Research Institution
      Osaka International Cancer Institute
  •  The efficacy of WT1 protein oral cancer vaccine on the brain tumor and the analysis of tumor-infiltrating lymphocytesPrincipal Investigator

    • Principal Investigator
      Minagawa Hikaru
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Osaka University
  •  Epitope analysis and investigation of the efficacy for human of oral cancer vaccine using BifidobacteriumPrincipal Investigator

    • Principal Investigator
      Minagawa Hikaru
    • Project Period (FY)
      2017 – 2018
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Pediatrics
    • Research Institution
      Osaka University

All 2023 2022 2018

All Journal Article Presentation

  • [Journal Article] Enhanced antitumor activity of a novel, oral, helper epitope-containing WT1 protein vaccine in a model of murine leukemia2023

    • Author(s)
      Minagawa Hikaru、Hashii Yoshiko、Nakajima Hiroko、Fujiki Fumihiro、Morimoto Soyoko、Nakata Jun、Shirakawa Toshiro、Katayama Takane、Tsuboi Akihiro、Ozono Keiichi
    • Journal Title

      BMC Cancer

      Volume: 23 Issue: 1 Pages: 167-167

    • DOI

      10.1186/s12885-023-10547-5

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07841, KAKENHI-PROJECT-23K06761
  • [Journal Article] An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia.2022

    • Author(s)
      1.Nakagawa N, Hashii Y, Kayama H, OkumuraR, Nakajima H, Minagawa H, Morimoto S, Fujiki F, Nakata J, Shirakawa T, Katayama T, Takeda K, Tsuboi A, Ozono K.
    • Journal Title

      Cancer Immunol Immunother.

      Volume: -

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07841
  • [Journal Article] An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia2022

    • Author(s)
      Nakagawa Natsuki、Hashii Yoshiko、Kayama Hisako、Okumura Ryu、Nakajima Hiroko、Minagawa Hikaru、Morimoto Soyoko、Fujiki Fumihiro、Nakata Jun、Shirakawa Toshiro、Katayama Takane、Takeda Kiyoshi、Tsuboi Akihiro、Ozono Keiichi
    • Journal Title

      Cancer Immunology, Immunotherapy

      Volume: 72 Issue: 1 Pages: 39-53

    • DOI

      10.1007/s00262-022-03214-4

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07841, KAKENHI-PROJECT-23K06761
  • [Presentation] The anti-tumor effect of oral cancer vaccine using Bifidobacterium as a platform for displaying Wilms’ tumor 1 protein2018

    • Author(s)
      皆川光
    • Organizer
      ASCO-SITC
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K16259
  • 1.  橋井 佳子 (60343258)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 2.  戸村 道夫 (30314321)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  香山 尚子 (40548814)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 4.  白川 利朗 (70335446)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 5.  片山 高嶺 (70346104)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi